Table 4.

Means and changes in insulin, glucose, and HOMA2 in women with >2% fat loss

Geometric mean
Baseline4 mo12 mo% change 0–4 mo% change 0–12 moβa (95% CI)
Insulin, μU/mL
 Control6.836.386.67−6.51−2.361.02 (0.87–1.19)
 Exercise7.447.326.88−1.55−7.49
Glucose, mmol/L
 Control5.265.155.14−2.13−2.351.02 (0.99–1.04)
 Exercise5.195.205.150.15−0.71
HOMA2
 Control0.780.720.75−6.91−2.921.02 (0.88–1.19)
 Exercise0.840.830.78−1.50−7.57

NOTE: In total, 69 women were considered in this analysis (n = 39 in the intervention and n = 30 in the control group). Data were missing for 2 women (1 control, 1 intervention) at 4 months, and for 1 woman (intervention) at 12 months.

  • aThe β (95% CI) is the treatment effect ratio representing the overall intervention effect on metabolic variable (adjusted for baseline), including changes from baseline to 4 months and 4 to 12 months. Because metabolic variables were log-transformed for the analysis, the regression coefficient is the anti-logarithm of the original coefficient. Therefore, the anti-logarithm of the coefficient is a ratio that indicates whether the hormone level is, on average, higher in the intervention group compared with controls (>1) or lower (<1); e.g., 1.01 indicates that the metabolic variable is on average 1% higher in the intervention group compared with controls.